34 Followers on Owler

BridgeBio

is a California-based commercial-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and genetic diseases... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights

BridgeBio

is a California-based commercial-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and genetic diseases... Read more
BridgeBio Co-Founder & CEO: Neil Kumar

Co-Founder & CEO

Neil Kumar

CEO Approval Rating

82/100

2014

PublicNASDAQBBIO

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
2836 NAICS listing

Annual Revenue
$351.6M
Employees
400
Funding
$4.7B
Investments
2

News

Funding
Jan 16, 2026
GlobalNewswire
BridgeBio received $550M in Post-IPO Debt Funding

BridgeBio Competitors

1BioMarin
2Ascendis Pharma
3Amolyt Pharma
4Ribomic
5Sanofi
6bluebird bio
7Spark Therapeutics
8Sangamo
9uniQure
10Intellia Therapeutics
Unlock 29 + competitors

Trending Companies